Do we have good surrogate endpoints for survival in breast cancer studies?

Tumori. 2000 Sep-Oct;86(5 Suppl 1):S4-10.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Breast Neoplasms / mortality*
  • Breast Neoplasms / pathology
  • Breast Neoplasms / therapy*
  • Clinical Trials as Topic
  • Disease Progression
  • Disease-Free Survival
  • Female
  • Humans
  • Lymphatic Metastasis
  • Quality of Life
  • Survival Analysis
  • Survival Rate
  • Treatment Outcome